Inactivated Vaccine Protects Layer Hens from Clade 2.3.4.4 H5 High Pathogenicity Avian Influenza Virus (2402)
Poultry Medicine |  Avian Influenza
Sunday | 10:15 AM - 10:30 AM
Henry B. Gonzalez Convention Center||221CD

 

Speaker(s)

Kateri Bertran Dols PhD
Southeast Poultry Research Laboratory, USDA-ARS

Kateri obtained her DVM from the Universitat Autònoma de Barcelona (Spain) and a PhD from the Centre de Recerca en Sanitat Animal in Barcelona (Spain). Her dissertation focused on avian influenza in minor avian species. She received training at the OIE reference centre for avian influenza and Newcastle disease (Padova, Italy). Currently, she is a visiting scientist at SEPRL working on transmission of avian influenza viruses at the animal-human interface, vaccine studies, and pathogenesis studies.

Presentation Info

CE Credit(s): 0.30
CE Level: 1

Description

An inactivated vaccine was tested in laying hens against North American clade 2.3.4.4 HPAI virus, proving protective from mortality and viral shedding even when challenged 6 months later. These studies support the use of inactivated vaccine for prevention of a North American clade 2.3.4.4 HPAI virus in layers.

Convention Notes

Convention notes require you to log in. Please click here to login